Genetic Study of Lupus Patients and Their Families
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00235378|
Recruitment Status : Completed
First Posted : October 10, 2005
Last Update Posted : October 15, 2015
|Condition or disease|
|Systemic Lupus Erythematosus|
Little is known about the genetic factors that predispose people to developing SLE. Genes in patients with SLE may provide clues about SLE's pathogenesis. This study will compare genes from SLE patients, their unaffected family members, and control participants. Travel to the study site is not required.
In this study, blood samples will be collected from people diagnosed with SLE, their unaffected family members, and condition-matched controls. Participants will be asked questions about their health and will provide a small blood sample. Participants will also be asked to provide written permission for release of medical information, so that their disease status can be verified through medical record review or through consultation with their doctors. Study personnel may contact participants in the future for follow-up questions and additional blood draws, if the participant agrees.
|Study Type :||Observational|
|Actual Enrollment :||2356 participants|
|Official Title:||Gene Mapping in Women With SLE|
|Study Start Date :||July 1996|
|Actual Primary Completion Date :||March 2013|
|Actual Study Completion Date :||March 2013|
Unaffected family members of SLE patients
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00235378
|United States, Minnesota|
|University of Minnesota|
|Minneapolis, Minnesota, United States, 55455|
|Principal Investigator:||Timothy W. Behrens, MD||University of Minnesota - Clinical and Translational Science Institute|
|Principal Investigator:||Patrick Gaffney||University of Minnesota - Clinical and Translational Science Institute|